Customized Use of Anti-Tumour Necrosis Factor-α Therapy During Pregnancy

被引：0
|
作者：
Seow, Cynthia H. [1 ]
Casteele, Niels Vande [2 ]
Panaccione, Remo [1 ]
机构：
[1] Univ Calgary, Dept Med, Calgary, AB, Canada
[2] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷 / 11期
关键词：
ADALIMUMAB; INFLIXIMAB;
D O I：
10.1093/ecco-jcc/jjy082
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1379 / 1380
页数：2
相关论文
共 50 条
  • [1] Mycobacterial diseases developed during anti-tumour necrosis factor-α therapy
    Yoo, Jung-Wan
    Jo, Kyung-Wook
    Kang, Bo-Hyung
    Kim, Mi Young
    Yoo, Bin
    Lee, Chang-Keun
    Kim, Yong-Gil
    Yang, Suk-Kyun
    Byeon, Jeong-Sik
    Kim, Kyung-Jo
    Ye, Byong Duk
    Shim, Tae Sun
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (05) : 1289 - 1295
  • [2] Anti-tumour necrosis factor-α therapies in Crohn's disease
    Sprakes, M. B.
    Hamlin, P. J.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (11) : 644 - 647
  • [3] Increased Serum Tumour Necrosis Factor-α in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor-α Agents?
    Matusiak, Lukasz
    Bieniek, Andrzej
    Szepietowski, Jacek C.
    ACTA DERMATO-VENEREOLOGICA, 2009, 89 (06) : 601 - 603
  • [4] Anti-tumour necrosis factor (TNF)-α therapy in undifferentiated spondyloarthropathy
    Schnarr, S
    Kuipers, JG
    Zeidler, H
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (06) : S126 - S129
  • [5] Anti-tumour necrosis factor-α treatment for perianal Crohn's disease in Australia
    Burger, Daniel C.
    Lawrance, Ian C.
    Bampton, Peter A.
    Prosser, Ruth
    Croft, Anthony
    Gilshenan, Kristen
    Radford-Smith, Graham L.
    Florin, Timothy H.
    MEDICAL JOURNAL OF AUSTRALIA, 2010, 192 (07) : 375 - 377
  • [6] Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema
    Tosi, G. M.
    Vitale, A.
    Rigante, D.
    Sota, J.
    Emmi, G.
    Lopalco, G.
    Guerriero, S.
    Iannone, F.
    Vannozzi, L.
    Bitossi, A.
    Frediani, B.
    Cantarini, L.
    Fabiani, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (04) : 621 - 625
  • [7] Structure-Modifying Capacity of Anti-Tumour Necrosis Factor-α Therapy in Ankylosing Spondylitis
    Filip De Keyser
    Dominique Baeten
    Filip Van den Bosch
    Elli Kruithof
    Gust Verbruggen
    Herman Mielants
    Eric Veys
    Drugs, 2004, 64 : 2793 - 2811
  • [8] Anti-Cytokine Strategies beyond Anti-Tumour Necrosis Factor-α Therapy: Pathophysiology and Clinical Implications
    Rogler, Gerhard
    Biedermann, Luc
    Scharl, Michael
    DIGESTIVE DISEASES, 2017, 35 (1-2) : 5 - 12
  • [9] Anti-Tumour Necrosis Factor-α Therapy for Rheumatoid and Other Inflammatory ArthropathiesUpdate on Safety in Older Patients
    Paul Ornetti
    Hélène Chevillotte
    Amal Zerrak
    Jean Francis Maillefert
    Drugs & Aging, 2006, 23 : 855 - 860
  • [10] Compassionate access anti-tumour necrosis factor- therapy for ulcerative colitis in Australia: the benefits to patients
    Costello, S. P.
    Ghaly, S.
    Beswick, L.
    Pudipeddi, A.
    Agarwal, A.
    Sechi, A.
    O'Connor, S.
    Connor, S. J.
    Sparrow, M. P.
    Bampton, P.
    Walsh, A. J.
    Andrews, J. M.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (06) : 659 - 666
12345